The Message From a Reader That Made Me Check My Own Medicine Cabinet
Short + DIrect Answer:
A sertraline recall affecting one specific UK batch was issued by the MHRA after some cartons were found to contain the wrong SSRI medication inside. If you take sertraline, checking your batch number takes under a minute and is genuinely worth doing, even though the issue itself was a packaging error rather than a problem with sertraline as a medication.
A reader sent me a link to a news story about sertraline recall and rightly asked nervously if that meant sertraline itself was going to be removed from the shelf. Her mother had been taking it for years, and the very word “memory” made her nervous before she could read the headline.
I understood this feeling perfectly. “Remember” is one of those words that causes a much more serious reaction than the situation in general, and withdrawal from medications in particular can be scary because most of us don’t fully understand how limited and specific they are in general.
It was this conversation that made me want to write it correctly instead of explaining a horrible headline. The sertraline reminder is real, but it is much more limited and explainable than the initial fear.
I think looking back at the original regulatory notice, rather than just the media coverage, what impresses me most is how trivial the real reason turned out. It was not a problem of contamination, nor of a defect in the formulation of the medicine, nor of a problem related to its formulation. It was a mistake on the packaging line, the kind of human and mechanical process failure that are really serious and can be corrected, but it’s a completely different concern than most imagine when they hear the word “recall.”
If you or a loved one takes sertraline, understanding what a sertraline recall is and isn’t is the difference between a two-minute package check and an unnecessary alarm.
Table of Contents
What Actually Happened
The recall centres on a packaging error, not a problem with sertraline as a drug. Amarox Limited, the manufacturer, discovered that one specific batch of sertraline 100mg film-coated tablets had been packaged incorrectly, with some sealed cartons containing a blister strip of citalopram 40mg tablets instead of, or alongside, the sertraline that should have been inside.
Quick fact
The error occurred during secondary packaging, the stage where blister strips are placed into their outer cartons. Amarox manufactures both sertraline and citalopram at the same facility, which is how a mix-up between the two ended up happening in the first place.
The affected batch, number V2500425, was first distributed in late November 2025, with the recall formally issued by the UK’s Medicines and Healthcare products Regulatory Agency as a Class 2 recall on 28 April 2026. Roughly 81,872 packs were included in the recall, though the MHRA has noted that the majority of the affected stock had likely already been dispensed and consumed well before the issue came to light.
That timeline is worth sitting with for a moment. Roughly five months passed between the batch first reaching pharmacies and the recall being formally issued, which explains why the MHRA’s guidance leans toward practical, immediate pack-checking rather than broader alarm. Most of that batch has simply already run its course through the supply chain and into patients’ hands without incident.
The mix-up was identified after a single patient complaint, someone who noticed the wrong tablets inside their sealed pack and reported experiencing a headache, which resolved once they stopped taking the incorrect medication.
There’s something worth appreciating in that detail too. A single attentive patient, checking their own medication closely enough to notice something was off, triggered a chain of events that led to a formal national recall within days. It’s a reminder that patients checking their own packs, which is essentially what this entire article is encouraging you to do, is a genuinely meaningful part of how these systems catch errors in the first place.
Why This Particular Mix-Up Matters
Sertraline and citalopram are both selective serotonin reuptake inhibitors, commonly known as SSRIs, prescribed for depression, anxiety, and related conditions. They work in broadly similar ways, by increasing serotonin availability in the brain, but they are not interchangeable, and taking one when you’re prescribed the other carries real, specific risks.
Who’s at higher risk
The MHRA specifically flagged patients over 65, patients under 18, those with existing cardiac or liver conditions, and people who are poor metabolisers of CYP2C19, a liver enzyme involved in processing certain medications, as groups who may need closer monitoring if they were affected. If you or someone you’re caring for falls into any of these categories, this recall is worth taking a little more seriously.
Co-administering two SSRIs, even briefly, raises the risk of increased serotonergic effects, and the product labelling for sertraline specifically flags QT prolongation, a cardiac rhythm concern, as a risk factor worth monitoring in vulnerable patients. None of this means harm was widespread. It means the precaution the MHRA took was medically sensible given who might have been affected.
I want to be careful here not to overstate the danger either. The single documented adverse event reported so far was a headache that resolved on its own. That’s genuinely reassuring, even while the precautionary monitoring guidance for higher-risk groups remains sensible and worth following if it applies to you.
What to Do If You Take Sertraline
Checking your own pack takes less time than reading this paragraph. Look at the outer carton for the batch number and expiry date, usually printed along the side or bottom of the box. If your batch number is V2500425, it’s worth opening the box and checking the blister strips themselves, since the labelling on the strip is what actually confirms which medication is inside.
If the strips inside are labelled sertraline, no further action is needed, even if your batch number matches the recalled one, since not every pack from that batch was affected. If the strips are labelled citalopram, stop taking them and contact your pharmacy as soon as possible. Do not simply stop your sertraline treatment without a plan, since stopping an SSRI abruptly can cause its own set of withdrawal-like symptoms, and your pharmacist or GP will want to arrange a proper replacement supply and, if needed, a treatment review.
If your batch number doesn’t match V2500425 at all, this recall simply doesn’t apply to you, and no action is needed beyond the reassurance of having checked.
I’d also gently push back on one instinct I’ve seen in reader comments elsewhere online: don’t assume you’re fine just because you can’t immediately locate the box. If you’ve been on the same prescription for a while and have genuinely disposed of the original packaging already, and you took your tablets without any unusual symptoms, that itself is reasonably strong evidence you weren’t affected. The recall only concerns one batch out of the many produced and distributed over time.
Symptoms to Watch For If You Took the Wrong Tablets
If you’ve already taken tablets from an affected pack without realising it, the MHRA and reporting so far point to relatively mild symptoms in most cases: headache, nausea, changes in sleep, and mild anxiety, consistent with a temporary increase in serotonergic activity from effectively taking two SSRIs together briefly.
These symptoms typically resolve once the incorrect medication is stopped. That said, if you experience anything more concerning, a rapid heartbeat, confusion, significant agitation, or symptoms that feel disproportionate or don’t settle, seek medical attention rather than waiting it out, particularly if you fall into one of the higher-risk groups mentioned earlier.
It’s worth mentioning that these symptoms overlap considerably with ordinary, everyday causes too, a bad night’s sleep, an unrelated headache, general stress. That overlap is precisely why the MHRA’s advice centres on checking the physical pack and batch number first, rather than trying to diagnose the situation from symptoms alone, which would understandably be far less reliable.
How Drug Recalls Like This Actually Happen
It’s worth understanding a little about how recalls like this get classified, because it genuinely changes how alarmed you should be. This was categorised as a Class 2 recall, meaning it could cause temporary or reversible harm in some patients, a real but moderate level of concern, rather than the more serious Class 1 designation reserved for situations with potential for serious harm or death.
Manufacturing and packaging errors happen occasionally across the pharmaceutical industry precisely because the systems designed to catch mistakes are not infallible, even in well-regulated facilities. What matters is how quickly an error is caught and acted on once identified, and in this case, the MHRA moved to a formal Class 2 recall within days of the manufacturer becoming aware of the complaint, which is the system working roughly as intended, even though the original error obviously shouldn’t have happened.
There’s also been fair criticism from within the pharmacy sector about who bears the operational burden when errors like this occur. Industry bodies have pointed out that community pharmacies, who did nothing wrong, end up absorbing the time and cost of managing the recall process, tracking down affected patients and reissuing prescriptions, while the financial responsibility sits with the manufacturer. It’s a reasonable point, and one worth being aware of if your own pharmacist seems a little stretched managing this alongside their usual workload.
This is also a useful moment to say plainly: this recall reflects a packaging error at one manufacturer, not a broader safety concern with sertraline as a medication. Sertraline remains one of the most widely prescribed and well-studied antidepressants available, and this incident doesn’t change that underlying safety profile.
I think it’s genuinely worth remembering that sertraline has been prescribed to hundreds of millions of people worldwide over several decades, with an extensively documented safety and efficacy record. A single packaging error at one manufacturing site, however seriously it needed to be addressed, doesn’t meaningfully change that broader picture, and I’d hate for this recall to become a reason someone stops a medication that’s genuinely helping them, without first talking it through with their doctor.
If medication safety and recalls are something you want to stay generally informed about, it’s worth browsing our Medication Awareness category, where we cover drug safety alerts and patient information as they arise. And if concerns about your own or a loved one’s mental health are part of why this recall feels particularly unsettling, our Mental Health category has further reading on anxiety, depression, and emotional wellbeing that may be useful alongside this.
For official, up-to-date UK drug recall information beyond what’s covered here, gov.uk/drug-device-alerts is the primary source worth bookmarking, and your pharmacist remains the most reliable first point of contact if you have any doubt about your own specific situation.
Frequently Asked Questions
What is the sertraline recall about?
It’s a Class 2 recall of one specific batch of sertraline 100mg tablets after some cartons were found to contain citalopram tablets instead, due to a packaging error at the manufacturing site.
Which batch of sertraline was recalled?
Batch number V2500425, manufactured by Amarox Limited, first distributed in late November 2025 and recalled by the MHRA on 28 April 2026.
What should I do if I have the recalled sertraline batch?
Check the blister strips inside the carton. If they’re labelled citalopram, stop taking them and contact your pharmacy promptly. If they’re labelled sertraline, no action is needed.
Is sertraline itself unsafe?
No. This recall reflects a packaging error at one manufacturer, not a safety concern with sertraline as a medication, which remains widely prescribed and well-studied.
Who is most at risk from this recall?
Patients over 65, under 18, those with cardiac or liver conditions, and people who are poor metabolisers of CYP2C19 were specifically flagged by the MHRA as groups who may need closer monitoring.
Final Thoughts: Check Your Pack, Then Don’t Panic
I told my reader roughly what I’ve laid out here: check the batch number, check the tablets themselves if it matches, and don’t stop taking sertraline on your own if everything checks out fine. The overwhelming likelihood, given how the numbers and timeline work out, is that most people affected have already taken correctly labelled medication without ever knowing there was an issue.
If you take sertraline, or you’re supporting someone who does, this sertraline recall is worth a two-minute check and nothing more dramatic than that. If anything about your own situation doesn’t quite match what’s covered here, your pharmacist is always the right first call.
Medical Disclaimer
This article is for general information only and is not a substitute for professional medical advice. Please consult your pharmacist or GP if you believe you have been affected by this recall or have any concerns about your medication.
